INS and diabetic ketoacidosis: These observations were accompanied by a significantly reduced prandial dose, basal dose, and TDD of insulin in all three treatment groups, but not at the expense of safety considerations, as no diabetic ketoacidosis or severe hypoglycemia were detected.